While human clinical trials remain the gold standard, the breadth and consistency of animal research offers valuable insights into what users might expect
That may be related to the possibility that people, when they are on GLP-1, they definitely eat a whole lot less to lose weight, but they also hydrate themselves less, Al-Aly said in a news briefing
shifts in TSH during early GLP-1 treatment may reflect weight-related metabolic adjustment rather than medication harm, but tracking trends ensures safety
For adult-only formulations, tirzepatide (Zepbound) is currently approved for individuals 18 years and older with a BMI of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related comorbidity such as hypertension or type 2 diabetes
ABSTRACT Background/Aims Previous studies have revealed that glucagon-like peptide-1 receptor agonist (GLP-1RA) and thiazolidinedione (TZD) can improve nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH)